A predictive mechanistic model of drug release from surface eroding polymeric nanoparticles.
A predictive mechanistic model of drug release from surface eroding polymeric nanoparticles.
复制标题
DOI:
10.1016/j.jconrel.2022.09.067
复制
发表时间:
2022-11
影响因子:
10.8
通讯作者:
Ainslie, Kristy M.
中科院分区:
文献类型:
--
作者:
Stiepel, Rebeca T.;Pena, Erik S.;Ehrenzeller, Stephen A.;Gallovic, Matthew D.;Lifshits, Liubov M.;Genito, Christopher J.;Bachelder, Eric M.;Ainslie, Kristy M.
Effective drug delivery requires ample dosing at the target tissue while minimizing negative side effects. Drug delivery vehicles such as polymeric nanoparticles (NPs) are often employed to accomplish this challenge. In this work, drug release of numerous drugs from surface eroding polymeric NPs was evaluated in vitro in physiologically relevant pH 5 and neutral buffers. NPs were loaded with paclitaxel, rapamycin, resiquimod, or doxorubicin and made from an FDA approved polyanhydride or from acetalated dextran (Ace-DEX), which has tunable degradation rates based on cyclic acetal coverage (CAC). By varying encapsulate, pH condition, and polymer, a range of distinct drug release profiles were achieved. To model the obtained drug release curves, a mechanistic mathematical model was constructed based on drug diffusion and polymer degradation. The resulting diffusion-erosion model accurately described drug release from the variety of surface eroding NPs. For drug release from varied CAC Ace-DEX NPs, the goodness of fit of the developed diffusion-erosion model was compared to several conventional drug release models. The diffusion-erosion model maintained optimal fit compared to conventional models across a range of conditions. Machine learning was then employed to estimate effective diffusion coefficients for the diffusion-erosion model, resulting in accurate prediction of in vitro release of dexamethasone and 3′ 3’-cyclic guanosine monophosphate–adenosine monophosphate from Ace-DEX NPs. This predictive modeling has potential to aid in the design of future Ace-DEX formulations where optimized drug release kinetics can lead to a desired therapeutic effect.
登录
查看更多内容
影响因子:
--
作者:
Amreddy N;Babu A;Muralidharan R;Panneerselvam J;Srivastava A;Ahmed R;Mehta M;Munshi A;Ramesh R
通讯作者:
Ramesh R
影响因子:
--
作者:
Gao Y;Zuo J;Bou-Chacra N;Pinto Tde J;Clas SD;Walker RB;Löbenberg R
通讯作者:
Löbenberg R
影响因子:
4.9
作者:
Collier MA;Junkins RD;Gallovic MD;Johnson BM;Johnson MM;Macintyre AN;Sempowski GD;Bachelder EM;Ting JP;Ainslie KM
通讯作者:
Ainslie KM
影响因子:
4.2
作者:
Bhattacharjee, Sourav
通讯作者:
Bhattacharjee, Sourav
DOI:
10.1073/pnas.0901592106
发表时间:
2009-04-07
影响因子:
11.1
作者:
Broaders, Kyle E.;Cohen, Joel A.;Frechet, Jean M. J.
通讯作者:
Frechet, Jean M. J.